BIOMARKERS FOR CHOLANGIOCELLULAR CARCINOMA (CCC)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160195537A1
SERIAL NO

14916583

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a method for identifying specific marker proteins (biomarkers) for cholangiocellular carcinoma (CCC), the biomarkers for CCC identified by the method and the use thereof, in particular for diagnosis, surveillance and treatment. The invention further relates to a diagnostic device comprising the biomarkers for CCC and a screening assay wherein these biomarkers for CCC are used to identify novel pharmaceutical compounds for treatment of CCC.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN - ISAS - E VBUNSEN-KIRCHHOFF-STRASSE 11 DORTMUND 44139

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BABA, Hideo A Essen, DE 1 3
BRACHT, Thilo Bochum, DE 2 6
MEGGER, Dominik A Dortmund, DE 2 6
MEYER, Helmut E Recklinghausen, DE 12 11
PADDEN, Juliet Bochum, DE 1 3
SCHLAAK, Jörg F Essen, DE 1 3
SITEK, Barbara Witten, DE 5 11
WEBER, Frank Essen, DE 61 1323

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation